MVP and vinorelbine for malignant pleural mesothelioma - Reply

www.thelancet.com Vol 372 August 23, 2008 629 Authors’ reply Improving the outcomes of patients with malignant pleural mesothelioma is a major challenge. Mesothelioma is a relatively rare disease, patients tend to be elderly and symptomatic, and, beyond palliation, treatment options are limited: radical surgery is only possible for a small minority MVP and vinorelbine for malignant pleural mesothelioma